Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
InstaDeep raises $100M to inject enterprise decision-making with AI
10:22am, Tuesday, 25'th Jan 2022 VentureBeat
InstaDeep, a company collaborating on AI solutions for organizations including Google AI and BioNTech, has raised $100 million in capital.
BioNTech, Google, Deutsche Bahn back African-founded AI firm
08:47am, Tuesday, 25'th Jan 2022
Vaccine maker BioNTech, Google and rail firm Deutsche Bahn are among the companies investing in African-founded artificial intelligence company InstaDeep.
Pfizer, BioNTech begin omicron-specific COVID-19 vaccine study
08:36am, Tuesday, 25'th Jan 2022
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Clinical Trials Begin For Pfizer And BioNTech's Omicron-Specific Covid Shot
07:23am, Tuesday, 25'th Jan 2022
The study will evaluate the safety and efficacy of a new shot designed to target the omicron coronavirus variant, which can evade some of the protection from existing vaccines.
Tunisian enterprise AI startup InstaDeep raises $100M from Alpha, BioNTech, Google
07:03am, Tuesday, 25'th Jan 2022
A recent survey carried out by CNBC reported that 81% of executives worldwide say AI will play a prominent and critical role in how their businesses operate this year. Companies are phasing from the f
Pfizer and BioNTech launch study to evaluate omicron-based COVID-19 vaccine for adults 18 to 55 years old
07:00am, Tuesday, 25'th Jan 2022
Pfizer Inc. PFE, -2.37% and German partner BioNTech SE BNTX, +2.36% said Tuesday they are launching a trial to evaluate an omicron-based COVID-19 vaccine in healthy adults aged 18 to 55. "While curren
Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron
06:45am, Tuesday, 25'th Jan 2022
Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March.
AstraZeneca, Pfizer/ BioNTech or J&J shots found to boost effect of Sinovac COVID-19 vaccine
04:25pm, Monday, 24'th Jan 2022 Seeking Alpha
A booster dose of AstraZeneca (AZN), Pfizer (PFE)/ BioNTech (BNTX), and Johnson & Johnson (JNJ) vaccines led to a significant increase in COVID-19 antibody levels in those who
Where Will BioNTech Be in 3 Years?
12:00pm, Monday, 24'th Jan 2022 The Motley Fool
It''ll be further along its way to becoming a drug development powerhouse.
UBS cuts BioNTech price target by 43% saying pandemic trade premium is fading
02:08pm, Friday, 21'st Jan 2022 Seeking Alpha
While still maintaining BioNTech at neutral, UBS has cut its price target to $170 from $300 (~9% upside based on yesterday close).
WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year olds
01:27pm, Friday, 21'st Jan 2022 Reuters
The World Health Organization''s advisory panel on Friday recommended extending the use of a reduced dosage of Pfizer and German partner BioNTech''s COVID-19 vaccine to children aged 5 to 11 years old.
Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week
09:35pm, Thursday, 20'th Jan 2022 The Motley Fool
Several factors are dragging down these vaccine stocks.
Pfizer Trends Sideways, But A Looming Catalyst Could Arrive Next Month
05:09pm, Thursday, 20'th Jan 2022 Investor''s Business Daily
White House advisor Anthony Fauci said U.S. officials could authorize Pfizer and BioNTech''s Covid vaccine for children younger than 5 next month.
Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week
04:35pm, Thursday, 20'th Jan 2022
Several factors are dragging down these vaccine stocks.
Fauci says FDA could clear Pfizer/BioNTech COVID-19 shot next month for kids under five
11:33am, Thursday, 20'th Jan 2022 Seeking Alpha
President Bidens chief medical advisor Dr. Anthony Fauci said on Wednesday that the FDA could authorize the Pfizer (PFE)/ BioNTech (BNTX) COVID-19 vaccine next month for children under
